Logo Logo
Hilfe
Hilfe
Switch Language to English

Herder, Christian ORCID logoORCID: https://orcid.org/0000-0002-2050-093X; Saito, Yoshiro ORCID logoORCID: https://orcid.org/0000-0002-0559-5889; Spagnuolo, Maria C. ORCID logoORCID: https://orcid.org/0009-0003-3228-8766; Maalmi, Haifa ORCID logoORCID: https://orcid.org/0000-0002-2910-1142; Shimizu, Misaki; Bönhof, Gidon J. ORCID logoORCID: https://orcid.org/0000-0003-1446-6592; Suzuki, Keita ORCID logoORCID: https://orcid.org/0000-0003-2833-4080; Rathmann, Wolfgang ORCID logoORCID: https://orcid.org/0000-0001-7804-1740; Peters, Annette ORCID logoORCID: https://orcid.org/0000-0001-6645-0985; Roden, Michael ORCID logoORCID: https://orcid.org/0000-0001-8200-6382; Ziegler, Dan ORCID logoORCID: https://orcid.org/0000-0001-8956-3552; Thorand, Barbara ORCID logoORCID: https://orcid.org/0000-0002-8416-6440 und Takamura, Toshinari ORCID logoORCID: https://orcid.org/0000-0002-4393-3244 (2024): Differential associations between selenoprotein P and distal sensorimotor polyneuropathy in people with and without diabetes: KORA F4/FF4 study. In: Free Radical Biology and Medicine, Bd. 223: S. 87-95 [PDF, 1MB]

Abstract

Background: Oxidative stress is a risk factor for distal sensorimotor polyneuropathy (DSPN). Selenoprotein P is a protein with antioxidant properties but has not been investigated in the context of DSPN. This study aimed to assess the associations between selenoprotein P and DSPN in people without and with type 2 diabetes (T2D).

Methods: Cross-sectional and prospective analyses were based on 1053 (including 217 with T2D) and 513 participants (including 79 with T2D), respectively, aged 61–82 years from the population-based KORA F4 survey. DSPN at baseline (KORA F4) and in the follow-up survey KORA FF4 was defined based on the Michigan Neuropathy Screening Instrument. Serum levels of full-length selenoprotein P were quantified by ELISA. Associations between selenoprotein P and prevalent or incident DSPN were estimated using logistic regression analysis adjusting for multiple confounders.

Results: Selenoprotein P levels were not associated with prevalent DSPN in the total sample. However, there was a significant interaction by diabetes status. Higher levels of selenoprotein P were associated with lower odds of prevalent DSPN in individuals without T2D (fully adjusted model: OR 0.825 [95 % CI 0.682, 0.998], p = 0.0476), but not in those with T2D (OR [95 % CI] 1.098 [0.829, 1.454], p = 0.5132; pinteraction = 0.0488). Selenoprotein P levels were not associated with incident DSPN over a follow-up of 6.5 years.

Conclusion: In individuals without T2D from the older general population, lower selenoprotein P levels were associated with a higher prevalence of DSPN. Whether the antioxidant properties of selenoprotein P are responsible for the observed associations remains to be elucidated in future research.

Dokument bearbeiten Dokument bearbeiten